| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 06/10/1997 | US5637489 Phosphinothricin-resistance gene, and its use |
| 06/10/1997 | US5637487 Genetic engineered polypeptide; used for immunization of chickens against coccidiosis |
| 06/10/1997 | US5637481 Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell |
| 06/10/1997 | US5637480 DNA molecules encoding bone morphogenetic protein-10 |
| 06/10/1997 | US5637477 Recombinant protein production and insect cell culture and process |
| 06/10/1997 | US5637476 Genetic engineering |
| 06/10/1997 | US5637470 Screening array using cells expressing recombinant α and β subunits of the mammalian large-conductance (maxi-K) potassium channel |
| 06/10/1997 | US5637462 Cathepsin C homolog |
| 06/10/1997 | US5637461 Ligands of HIV-1 TAT protein |
| 06/10/1997 | US5637459 Systematic evolution of ligands by exponential enrichment: chimeric selex |
| 06/10/1997 | US5637456 Rapid test for determining the amount of functionally inactive gene in a gene therapy vector preparation |
| 06/10/1997 | US5637455 HIV-2 virus variants |
| 06/10/1997 | US5637300 Contraceptive vaccine comprising a glycosylated 55 kD zona pellucida protein immunogen and method of use of the same in contraception |
| 06/08/1997 | CA2192253A1 Geranylgeranyl diphosphate synthase proteins, nucleic acid molecules and uses thereof |
| 06/05/1997 | WO1997021089A1 Optical cuvette |
| 06/05/1997 | WO1997020078A1 Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| 06/05/1997 | WO1997020075A1 Screening assay for compounds stimulating somatostatin and insulin production |
| 06/05/1997 | WO1997020074A1 Electronically-solid-phase assay biomolecules |
| 06/05/1997 | WO1997020073A1 Method of determining the sequence of nucleic acids employing solid-phase particles carrying transponders |
| 06/05/1997 | WO1997020069A1 Method of detecting telomerase activity |
| 06/05/1997 | WO1997020068A2 Method for generating multiple double stranded nucleic acids |
| 06/05/1997 | WO1997020067A2 Process for detecting the expression of cd95 in cells |
| 06/05/1997 | WO1997020064A2 Process for assessing the activity of drugs |
| 06/05/1997 | WO1997020063A1 THEREAPEUTIC APPLICATIONS FOR THE ANTI-T-BAM (CD40-L) MONOCLONAL ANTIBODY 5c8 |
| 06/05/1997 | WO1997020060A1 Conditionally replicating viral vectors and their use |
| 06/05/1997 | WO1997020059A1 Recombinant live vaccine containing feline herpes virus type 1, particularly for treating feline infectious peritonitis |
| 06/05/1997 | WO1997020058A2 PLANT GENE EXPRESSION VECTOR FAMILY BASED ON THE REGULATORY DNA SEQUENCES OF AN ALFALFA H3 HISTONE GENE VARIANT (MsH3g1) |
| 06/05/1997 | WO1997020057A1 Root specific promoters |
| 06/05/1997 | WO1997020056A2 Enhancer-increased gene expression in plants |
| 06/05/1997 | WO1997020055A1 Use of anti-sense sequences to increase responsiveness to gene amplification |
| 06/05/1997 | WO1997020054A1 Recombinant poxvirus-feline infectious peritonitis virus, compositions thereof and methods for making and using them |
| 06/05/1997 | WO1997020052A1 Recombinant hiv and modified packaging cells and method for treating acquired immune deficiency syndrome |
| 06/05/1997 | WO1997020051A2 Vectors and methods for gene transfer to cells |
| 06/05/1997 | WO1997020050A1 Therapeutic and diagnostic compositions |
| 06/05/1997 | WO1997020049A1 Human peptide circulating in the blood and possessing insulinotropic properties |
| 06/05/1997 | WO1997020048A2 Modified sfv molecules which mediate adhesion between cells and uses thereof |
| 06/05/1997 | WO1997020047A1 Methods and compositions for the diagnosis and treatment of cancer |
| 06/05/1997 | WO1997020046A1 Dnam, an nk antigen and adhesion molecule of the immunoglobulin superfamily |
| 06/05/1997 | WO1997020045A2 P2u2 PURINERGIC RECEPTOR |
| 06/05/1997 | WO1997020043A1 Protein c production in transgenic animals |
| 06/05/1997 | WO1997020042A1 Sugar chain-deficient tissue plasminogen activator derivatives |
| 06/05/1997 | WO1997020040A1 Starch branching enzyme ii of potato |
| 06/05/1997 | WO1997020034A1 Auxinic analogues of indole-3-acetic acid |
| 06/05/1997 | WO1997020033A1 Salmonella vaccines |
| 06/05/1997 | WO1997020031A2 Rna polymerase ii carboxyl terminal domain-derived peptides |
| 06/05/1997 | WO1997019998A1 An enzyme for dying keratinous fibres |
| 06/05/1997 | WO1997019957A1 High efficiency tissue specific compound delivery system using streptavidin-protein a fusion protein |
| 06/05/1997 | WO1997019956A1 Method for control of functionality during cross-linking of hemoglobins |
| 06/05/1997 | WO1997019952A1 The ob receptor and methods of diagnosing and treating weight |
| 06/05/1997 | WO1997019950A1 Topiramate immunoassay, as well as analogs and antibodies |
| 06/05/1997 | WO1997019856A2 Plate-shaped holder housing for daily use and/or consumer articles |
| 06/05/1997 | WO1997019695A1 Method for treating retinal ganglion cell injury using glial cell line-derived neurotrophic factor (gdnf) protein product |
| 06/05/1997 | WO1997019694A1 Methods for treating photoreceptors using glial cell line-derived neurotrophic factor (gdnf) protein product |
| 06/05/1997 | WO1997019688A1 Non-toxic mutants of pathogenic gram-negative bacteria |
| 06/05/1997 | WO1997019589A1 Method for development of transgenic goats |
| 06/05/1997 | WO1997017444A3 Novel sperm receptors |
| 06/05/1997 | WO1997015677A3 New strains of bacillus thuringiensis and pesticide composition containing them |
| 06/05/1997 | WO1997014809A3 Novel expression vectors and methods of use |
| 06/05/1997 | WO1997013858A3 Baboon mage-3 homologs, dna encoding the homologs, and a process for their use |
| 06/05/1997 | WO1997012036A3 Bone stimulating factor |
| 06/05/1997 | WO1997010851A3 Nucleic acid delivery vehicle |
| 06/05/1997 | WO1997010334A3 Ribozyme therapy for the treatment and/or prevention of restenosis |
| 06/05/1997 | WO1997007219A3 Genes and proteins controlling cholesterol synthesis |
| 06/05/1997 | WO1996039530A3 Recombinant adenovirus and adeno-associated virus, cell lines, and methods of production and use thereof |
| 06/05/1997 | DE19651001A1 Mammalian VAT1-homologous protein, derived peptide(s), antibodies and cDNA |
| 06/05/1997 | DE19644302A1 Verfahren zum Nachweis von Telomerase-Aktivität A method for the detection of telomerase activity |
| 06/05/1997 | DE19549417A1 Luminometric determination of mutagenic or carcinogenic activity |
| 06/05/1997 | DE19544333A1 Verfahren zur Beurteilung der Aktivität von Arzneistoffen A method for assessing the activity of drugs |
| 06/05/1997 | DE19544332A1 Verfahren zum Nachweis der Expression von CD95 Ligand in Zellen A method of detecting expression of CD95 ligand in cells |
| 06/05/1997 | DE19543265A1 Autoantigene und Verfahren zur Diagnose von Autoimmunkrankheiten Autoantigens and method for diagnosis of autoimmune diseases |
| 06/05/1997 | CA2239180A1 Method for development of transgenic goats |
| 06/05/1997 | CA2238943A1 Root specific promoters |
| 06/05/1997 | CA2238829A1 Methods and compositions for the diagnosis and treatment of cancer |
| 06/05/1997 | CA2238696A1 Electronically-solid-phase assay biomolecules |
| 06/05/1997 | CA2238645A1 Method of determining the sequence of nucleic acids employing solid-phase particles carrying transponders |
| 06/05/1997 | CA2238569A1 The ob receptor and methods of diagnosing and treating weight |
| 06/05/1997 | CA2237937A1 Novel purinergic receptor |
| 06/05/1997 | CA2237823A1 Method of detecting telomerase activity |
| 06/05/1997 | CA2236868A1 Conditionally replicating viral vectors and their use |
| 06/05/1997 | CA2236794A1 Method for control of functionality during cross-linking of hemoglobins |
| 06/05/1997 | CA2236574A1 Therapeutic and diagnostic compositions |
| 06/05/1997 | CA2235962A1 Use of anti-sense sequences to increase responsiveness to gene amplification |
| 06/05/1997 | CA2207738A1 Optical tube and method |
| 06/05/1997 | CA2191833A1 Process for dienone macrolides |
| 06/04/1997 | EP0776981A2 Oligonucleotide primers for amplifying HCV nucleic acid |
| 06/04/1997 | EP0776975A2 Method for use of the yeast-ADH-II promotersystem for the biotechnological production of heterologous proteins in high yield |
| 06/04/1997 | EP0776974A2 Actinomycete promoter |
| 06/04/1997 | EP0776973A1 Fatty aldehyde decarbonylase for transforming bacterial cells and plants |
| 06/04/1997 | EP0776972A1 GENE CODING FOR IgG-Fc-BINDING PROTEIN |
| 06/04/1997 | EP0776971A1 Hyperthermostable protease gene |
| 06/04/1997 | EP0776970A1 Stable enzyme composition comprising a thermostable nucleic acid polymerase enzyme |
| 06/04/1997 | EP0776967A2 Heat exchanger for use in a temperature cycling instrument |
| 06/04/1997 | EP0776375A1 OLIGONUCLEOTIDES AND METHODS FOR THE DETECTION OF $i(NEISSERIA GONORRHOEAE) |
| 06/04/1997 | EP0776370A1 Human erythropoietin receptor fragment and antibodies thereto |
| 06/04/1997 | EP0776369A1 Dna sequences encoding porcine pancreatic carboxypeptidase b |
| 06/04/1997 | EP0776368A2 Protein toxins active against lepidopteran pests |
| 06/04/1997 | EP0776367A1 Dna encoding turkey hypothalamic vasoactive intestinal peptide |
| 06/04/1997 | EP0776366A1 Chimeric proteins and muteins of tissue factor pathway inhibitors tfpi and tfpi-2 |
| 06/04/1997 | EP0776365A2 Retinoblastoma protein-interacting zinc finger proteins |
| 06/04/1997 | EP0776364A1 Glutamate receptor |